When analyzing stocks, listening to interviews or reading reports conducted by equity research analysts on Wall Street can be ...

Investing.com -- 在知名做空者Andrew Left领导的Citron Research发布看好报告后，Teladoc Health Inc (NYSE: TDOC)股价上涨6%。Citron的背书将Teladoc描述为"未被充分关注的人工智能投资标的"，并赞扬了其最近对Catapult Health的收购以及有效利用技术提高盈利能力和扩大利润率的举措。

Shares of telemedicine company Teladoc Health (NYSE: TDOC) surprisingly popped on Thursday after Citron Research gave it a ...

The positive assessment by Citron Research comes at a time when Teladoc is working to redefine its market position and investor expectations. While the market has yet to fully acknowledge the ...

Radar' AI Play 2:57 pm Citron Research has come out touting Teladoc Health (Nasdaq: TDOC) as an “under-the-radar” AI stock.

Teledoc (TDOC), which just acquired Catapult Health, is using technology the “right” way, by cutting costs, improving care, and expanding ...

Citron Research analysts argue that the online healthcare company could be a smart purchase for Amazon or CVS.

Jefferies now values BABA’s cloud business at four times its revenue or about $60 billion, up from its previous estimate of ...